Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Invesco Nasdaq Biotechnology ETF IBBQ
$21.13
+$0.01 (0.05%)
На 18:04, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
22.17
-
week52low
16.73
-
Revenue
-
P/E TTM
-
Beta
0.00000000
-
EPS
1.25214000
-
Last Dividend
0.16100000
-
Next Earnings Date
07 мая 2023 г. в 07:29
Описание компании
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha
11 янв 2023 г. в 18:09
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
IBBQ: Healthcare Dashboard For December
Seeking Alpha
18 дек 2022 г. в 05:00
The pharmaceuticals/biotechnology subsector has good value and quality scores. The healthcare equipment industry is significantly overvalued.
Why Now Could Be The Time To Consider Neuroscience Investments
Seeking Alpha
27 авг 2022 г. в 04:45
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.
Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs
ETF Trends
03 авг 2022 г. в 18:23
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its latest quarterly report, along with a share buyback plan. On Wednesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) increased 4.2%, the ETFMG Treatments Testing and Advancements ETF (GERM) advanced 5.
Pharma & Biotech ETFs at One-Month High: Here's Why
Zacks Investment Research
08 июл 2022 г. в 09:20
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.